| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.075 | 0.1 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.1 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.084 | 0.1 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |